Literature DB >> 18468523

Combating counterfeit drugs.

.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18468523     DOI： 10.1016/S0140-6736(08)60663-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Caveat oncologist: clinical findings and consequences of distributing counterfeit erythropoietin in the United States.

Authors:  Zaina P Qureshi; Leann Norris; Oliver Sartor; June M McKoy; John Armstrong; Dennis W Raisch; Vishvas Garg; Dana Stafkey-Mailey; Charles Lee Bennett
Journal:  J Oncol Pract       Date:  2011-12-13       Impact factor: 3.840

2.  Poor quality vital anti-malarials in Africa - an urgent neglected public health priority.

Authors:  Paul N Newton; Michael D Green; Dallas C Mildenhall; Aline Plançon; Henry Nettey; Leonard Nyadong; Dana M Hostetler; Isabel Swamidoss; Glenn A Harris; Kristen Powell; Ans E Timmermans; Abdinasir A Amin; Stephen K Opuni; Serge Barbereau; Claude Faurant; Ray C W Soong; Kevin Faure; Jonarthan Thevanayagam; Peter Fernandes; Harparkash Kaur; Brian Angus; Kasia Stepniewska; Philippe J Guerin; Facundo M Fernández
Journal:  Malar J       Date:  2011-12-13       Impact factor: 2.979

Review 3.  Facing Counterfeit Medications in Sexual Medicine. A Systematic Scoping Review on Social Strategies and Technological Solutions.

Authors:  Andrea Sansone; Béatrice Cuzin; Emmanuele A Jannini
Journal:  Sex Med       Date:  2021-10-04       Impact factor: 2.491
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.